The NIH has issued a notice stating how the FY11 appropriation will affect funding. The Appropriation Act for FY11 allocates $30.9 billion to NIH, which is nearly 1% less than the amount NIH received in FY10 ($31.2B). As a result, “Modular and non-modular research grants, from all ICs, with the single exception of NCI, will be reduced to 1 percent below the FY 2010 award level. Inflationary adjustments for recurring costs on non-competing research grants in FY 2012 and beyond will be set at the 2 percent level, calculated based on the adjusted FY 2011 level.” The policy does not apply to K awards, SBIR/STTRs, and NRSAs. However, “Awards that have already been made in FY 2011 which are impacted by this policy may be revised.”
As for NCI, research grants will be reduced to 3% below FY10 levels. “Inflationary adjustments for recurring costs on non-competing research grants in FY 2012 and beyond will be set at the 2 percent level, calculated based on the adjusted FY 2011 level.” (Does not apply to Ks, SBIR/STTRs, nor NRSAs.) Again, awards made in FY11 may be revised based on this policy.
NIH anticipates that its ICs will award 9,050 new and competing Research Project Grants (RPGs). It will be up to each IC to apportion its extramural grant money in accordance with their funding priorities. (Future inflationary adjustments for recurring costs on competing grants will be 2%, and awards made in FY11 may be revised.)
New Investigators submitting R01 equivalent awards will be funded at rates comparable to those for established investigators submitting new R01 equivalent awards. NRSAs will get a 2% increase on stipends.